Literature DB >> 1396934

Acute deteriorations in neonatal chronic lung disease.

B Yuksel1, A Greenough.   

Abstract

Preterm infants with chronic lung disease (CLD) have frequent respiratory relapses. The aim of this study was to assess the aetiology of such deteriorations and in particular the proportion due to viral infections. During the study period 118 preterm infants with birth weight less than 1500 g were consecutively admitted to the neonatal intensive care unit; 22 (18.6%) developed CLD. At the onset of all respiratory deteriorations, infants were examined for the presence of patent ductus arteriosus, apnoea or aspiration; they were also carefully screened for both viral and bacterial infection. The 22 infants had a total of 74 episodes of respiratory deterioration; median 3 per baby (range 1-8). Two episodes were associated with patent ductus arteriosus, 18 with apnoea and 5 with aspiration. Infection was suspected or proven in association with all other episodes. On ten occasions the infants had positive blood cultures and on a further eight, bacteria were isolated only from the endotracheal or nasopharyngeal secretions. On the remaining 31 occasions, 27 associated with chest X-ray film abnormalities, infection was suspected, but no bacteria isolated. Viral infections were identified in association with 8 (11%) of these episodes. We conclude viral infection should be considered as a cause of otherwise unexplained respiratory deteriorations in infants with neonatal CLD.

Entities:  

Mesh:

Year:  1992        PMID: 1396934     DOI: 10.1007/bf01957577

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  32 in total

Review 1.  Neonatal neutrophil host defense. Prospects for immunologic enhancement during neonatal sepsis.

Authors:  M S Cairo
Journal:  Am J Dis Child       Date:  1989-01

Review 2.  Treatment of sepsis with IgG in very low birthweight infants.

Authors:  A Whitelaw
Journal:  Arch Dis Child       Date:  1990-04       Impact factor: 3.791

3.  Impact of treatment guidelines on use of ribavirin.

Authors:  K D Herzog; S S Long; M McGuigan; M C Fisher; A Deforest
Journal:  Am J Dis Child       Date:  1990-09

4.  Evaluation of an intravenous immunoglobulin preparation for the prevention of viral infection among hospitalized low birth weight infants.

Authors:  P A Piedra; J A Kasel; H J Norton; W C Gruber; J A Garcia-Prats; C J Baker
Journal:  Pediatr Infect Dis J       Date:  1990-07       Impact factor: 2.129

5.  Apnoea, bradycardia, and oxygen saturation in preterm infants.

Authors:  C J Upton; A D Milner; G M Stokes
Journal:  Arch Dis Child       Date:  1991-04       Impact factor: 3.791

6.  Development of the immune system in very low birth weight (less than 1500 g) premature infants: concentrations of plasma immunoglobulins and patterns of infections.

Authors:  M Ballow; K L Cates; J C Rowe; C Goetz; C Desbonnet
Journal:  Pediatr Res       Date:  1986-09       Impact factor: 3.756

7.  Aerosolized ribavirin treatment of respiratory syncytial virus infection in infants hospitalized during an epidemic.

Authors:  D A Conrad; J C Christenson; J L Waner; M I Marks
Journal:  Pediatr Infect Dis J       Date:  1987-02       Impact factor: 2.129

8.  Home oxygen therapy following neonatal intensive care.

Authors:  A Greenough; M F Hird; H R Gamsu
Journal:  Early Hum Dev       Date:  1991-07       Impact factor: 2.079

9.  Antireflux surgery in infants with bronchopulmonary dysplasia.

Authors:  R M Giuffre; S Rubin; I Mitchell
Journal:  Am J Dis Child       Date:  1987-06

10.  Childhood asthma following hospitalization with acute viral bronchiolitis in infancy.

Authors:  P D Sly; M E Hibbert
Journal:  Pediatr Pulmonol       Date:  1989
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.